4250 Duffy-binding-like domain, N-terminal subdomain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic oxygen compounds | 2 | 1.2 | 1.70× | not tested | |
| Homogeneous non-metal compounds | 2 | 1.3 | 1.57× | not tested | |
| Organic acids and derivatives | 1 | 0.9 | 1.09× | not tested | |
| Homogeneous metal compounds | 2 | 2.9 | 0.69× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00172 | PRO | Proline | 1 |
| DB01872 | ASG | 2-deoxy-2-acetamido-beta-D-galactose-4-sulfate | 1 |
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 1 |
| DB03896 | 3PO | Triphosphoric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 5 |
| MGmetal | MAGNESIUM ION | 2 |
| SIA | N-acetyl-alpha-neuraminic acid | 2 |
| 3PO | TRIPHOSPHATE | 1 |
| BEN | BENZAMIDINE | 1 |
| DHL | 2-AMINO-ETHANETHIOL | 1 |
| PRO | PROLINE | 1 |
| ZNmetal | ZINC ION | 1 |